Donepezil hydrochloride
Donepezil Hydrochloride
Donepezil hydrochloride (pronunciation: doh-NEP-eh-zil HYE-droe-KLOR-ide) is a medication primarily used in the treatment of Alzheimer's disease. It is classified under the drug class known as cholinesterase inhibitors.
Etymology
The term "Donepezil" is derived from the name of the pharmaceutical company, Eisai, that first developed the drug. "Hydrochloride" refers to the hydrochloride salt form of the drug, which enhances its solubility and bioavailability.
Pharmacology
Donepezil hydrochloride works by increasing the levels of a chemical called acetylcholine in the brain, which can help to slow down the progression of symptoms in Alzheimer's disease. It does this by inhibiting the action of an enzyme called acetylcholinesterase, which breaks down acetylcholine in the brain.
Usage
Donepezil hydrochloride is used to treat the symptoms of dementia in people diagnosed with mild to moderate Alzheimer's disease. It can help to improve cognitive function, including memory, attention, and the ability to interact with others.
Side Effects
Common side effects of Donepezil hydrochloride include nausea, vomiting, diarrhea, loss of appetite, and weight loss. More serious side effects can include slow heartbeat, fainting, and difficulty urinating.
Related Terms
See Also
External links
- Medical encyclopedia article on Donepezil hydrochloride
- Wikipedia's article - Donepezil hydrochloride
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski